Provider Observations of Youth with Early Onset Severe Obesity in Tertiary Care Obesity Programs

Bethany J Gaffka1, Sandra G Hassink2, Melissa Santos3

  • 11 Department of Pediatrics, University of Michigan C.S. Mott Children's and Von Voigtlander Women's Hospital , Ann Arbor, MI.

Insights

Healthcare providers observe that young children with severe obesity often exhibit dysfunctional eating patterns and externalizing behaviors. These insights can guide interventions for early-onset severe obesity management.

Area of Science:

  • Pediatrics
  • Obesity Medicine
  • Child Psychology

Background:

  • Severe obesity affects over 2% of children aged 2-5 years.
  • Limited understanding of characteristics guiding healthcare professionals.
  • Need to examine practitioner observations in clinical settings.

Purpose of the Study:

  • To describe provider observations of young children with severe early-onset obesity.
  • To identify key characteristics to inform clinical management and intervention.

Main Methods:

  • 72 interdisciplinary healthcare providers completed a semistructured online questionnaire.
  • 10 open-ended questions covered nutrition, behavior, family, medical history, and routines.
  • Grounded theory methods were used for data analysis.

Main Results:

  • Parent-described dysfunctional food approach (hunger, food seeking, lack of satiety) was most common.
  • Other characteristics included externalizing behaviors (tantrums, ADHD), developmental delays, comorbidities (asthma, sleep apnea), and unstructured home environments.

Conclusions:

  • This study is the first to describe provider observations of young children with severe early-onset obesity.
  • Findings can inform further education and potential clinical subtyping.
  • Observations offer opportunities to identify target areas for intervention.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
268
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
286
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
190
Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care...
2.2K
Nomenclature of Secondary and Tertiary Amines01:12

Nomenclature of Secondary and Tertiary Amines

The secondary and tertiary amines are derivatives of ammonia, where two and three of its hydrogens are replaced by alkyl groups, respectively. Secondary and tertiary amines can be symmetrical with identical alkyl groups attached to the nitrogen atom or unsymmetrical when more than one type of alkyl group is present. The standard nomenclature of secondary and tertiary amines is similar to the names given to the primary amines. They are generally named alkylamines. As depicted in Figure 1, for...
5.2K